Relative Bioavailability of Evobrutinib Tablet Batches
Clinical trial NCT07214922 · COMPLETED
Trial details
- NCT number
- NCT07214922
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-18
- Primary completion
- 2023-02-24
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.